Sionna Therapeutics (SION) Net Equity Issued and Repurchased (2024)

Sionna Therapeutics (SION) reported Net Equity Issued and Repurchased of $181.3 million for Q1 2024.

Sionna Therapeutics (SION) Net Equity Issued and Repurchased (2024) Analysis & Trends

Sionna Therapeutics (SION) has 1 years of Net Equity Issued and Repurchased data on file, last reported at $181.3 million in Q1 2024.

For the quarter ending Q1 2024, Net Equity Issued and Repurchased changed N/A year-over-year to $181.3 million; the trailing twelve-month figure through Dec 2024 stood at $181.3 million (changed N/A YoY), and the FY2024 full-year result was $181.3 million, changed N/A from the prior year.
Net Equity Issued and Repurchased steadied at $181.3 million in Q1 2024.
In the past five years, Net Equity Issued and Repurchased ranged from a high of $181.3 million in Q1 2024 to a low of $181.3 million in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	163.10 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	141.90 Mn
10	Sionna Therapeutics	1.98 Bn	1.98 Bn	-	-

Download Data

Date	Value
Mar 31, 2024	181.33 Mn
Mar 31, 2024	181.33 Mn